Clinical studies that specifically tested vitamin B6 (pyridoxine) for lowering prolactin in women have used doses between 200 and 600 mg per day, which is roughly 100 to 350 times the recommended daily allowance. The evidence behind those doses, however, is thin and inconsistent. A handful of small studies from the late 1970s through recent trials show that high-dose B6 can reduce prolactin in some women, but the results vary widely, and the doses involved carry real risks of nerve damage.
Why B6 Has Anything to Do With Prolactin
Prolactin is secreted by cells in the pituitary gland called lactotrophs, and these cells are naturally active: they release prolactin continuously unless something tells them to stop. The main “off switch” is dopamine, which binds to receptors on lactotrophs and suppresses both the release of prolactin and the gene activity that produces it.1Endocrine Reviews. Dopamine as a Prolactin Inhibitor This is why prescription drugs for high prolactin, like cabergoline and bromocriptine, work by mimicking dopamine at those same receptors.2PubMed. Prolactin and dopamine: what is the connection? A review article
Vitamin B6 enters the picture because its active form, pyridoxal 5′-phosphate (PLP), is a required cofactor for the enzyme that converts L-DOPA into dopamine. Without enough B6, dopamine synthesis slows down. In rat studies, B6 deficiency didn’t reduce the total amount of dopamine stored in the brain, but it significantly delayed the speed at which dopamine was released when neurons fired.3The Journal of Nutrition. Vitamin B-6 Deficiency Prolongs the Time Course of Evoked Dopamine Release from Rat Striatum The reasoning behind B6 supplementation is straightforward: more B6 should mean more efficient dopamine production, which should mean more prolactin suppression. Whether that logic holds up at the doses people actually take is where things get complicated.
The Doses That Have Been Studied in Women
The most directly relevant evidence for women comes from a small clinical report that treated three women who had the galactorrhea-amenorrhea syndrome, a condition where elevated prolactin causes breast milk production and loss of menstrual periods. These women received pyridoxine at doses between 200 and 600 mg per day. All three saw their prolactin levels return to the normal range, their galactorrhea stopped, and they resumed regular ovulatory menstrual cycles within roughly 37 to 94 days.4The Journal of Clinical Endocrinology & Metabolism. TREATMENT OF WOMEN WITH THE GALACTORRHEA-AMENORRHEA SYNDROME WITH PYRIDOXINE (VITAMIN B6) That sounds promising, but three patients is an extremely small number, and there was no placebo comparison group.
A larger study tested 600 mg per day (split into two 300 mg doses) in patients with antipsychotic-induced high prolactin. Over 16 weeks, prolactin levels dropped by about 68%, falling from elevated levels to near-normal ranges.5PubMed Central. Safety and Efficacy of High-Dose Vitamin B6 as an Adjunctive Treatment for Antipsychotic-Induced Hyperprolactinemia in Male Patients With Treatment-Resistant Schizophrenia That’s a striking result, but an important caveat: those patients were all male. Prolactin regulation differs between sexes, and you can’t assume the same magnitude of effect in women. Still, the study provides the strongest controlled evidence that very high-dose B6 can meaningfully lower prolactin in humans.
Laboratory research offers some additional context. When the active form of B6 was applied directly to pituitary cells in a dish, it reduced prolactin secretion by about 65 to 70% and dramatically slowed the growth of prolactin-producing cells.6PubMed Central. Pyridoxal phosphate inhibits pituitary cell proliferation and hormone secretion These were rat cells exposed to concentrations far higher than what oral supplements would deliver to the pituitary, so the real-world relevance is limited. But the findings do confirm that B6’s active form has a direct effect on the cells that produce prolactin, beyond just supporting dopamine synthesis.
What Happened When B6 Was Tested for Lactation Suppression
One of the largest bodies of evidence on B6 and prolactin in women comes from postpartum lactation studies, where the goal was to stop breast milk production by driving down prolactin. A systematic review of these trials found that women were typically given 450 to 600 mg per day for five to seven days. Two trials with a combined 349 women reported that B6 successfully inhibited lactation in about 95% of participants. But every other study the reviewers examined failed to show B6 was effective, whether measured by clinical assessment or by prolactin levels. The reviewers concluded that the evidence supporting high-dose B6 for lactation inhibition is “inconsistent and insufficient.”7PubMed. Is pyridoxine effective and safe for post-partum lactation inhibition? A systematic review
That split in findings is telling. It suggests that B6 may work for some women but not others, or that the positive results were influenced by study design rather than the vitamin itself. Either way, you’re looking at a supplement where the majority of controlled studies failed to produce the expected outcome.
How B6 Compares to Actual Prolactin-Lowering Medications
If you’re weighing B6 against prescription options, the gap in effectiveness is substantial. A randomized controlled trial that directly compared pyridoxine to cabergoline (a common prescription prolactin-lowering drug) for lactation inhibition found that cabergoline worked in 78% of women by day seven, while pyridoxine worked in only 35%.8American Journal of Obstetrics and Gynecology. The efficiency of cabergoline vs pyridoxine for lactation inhibition—a randomized controlled trial Women in the cabergoline group also reported less breast pain and engorgement.
A broader systematic review that pooled data from multiple trials comparing B6 to dopaminergic agonists (both cabergoline and bromocriptine) confirmed the pattern: the prescription drugs produced significantly greater lactation inhibition than B6, and the difference was statistically clear.9PubMed. Comparing pyridoxine with dopaminergic agonists (cabergoline and bromocriptine): Unveiling the strategy for lactation inhibition – A systematic review of clinical trials This isn’t surprising when you think about the mechanism. Prescription dopamine agonists bind directly to the D2 receptors on prolactin-producing cells. They’re essentially a targeted key for a specific lock. B6, by contrast, is an indirect player: it helps the body make more dopamine, which then has to travel to the pituitary and compete with everything else going on. It’s a few steps removed from the action, and each step introduces variability.
None of this means B6 is useless. For someone with mildly elevated prolactin who wants to try a supplement before pursuing medication, or for someone who can’t tolerate dopamine agonists, B6 might be worth discussing with a doctor. But if your prolactin is high enough to cause symptoms like missed periods, unwanted breast discharge, or fertility problems, prescription options are far more reliable.
The Safety Problem with High-Dose B6
The recommended dietary allowance for B6 in adult women is between 1.3 and 1.7 mg per day, depending on age and whether you’re pregnant or breastfeeding.10PubMed Central. Expert Consensus on Vitamin B6 Therapeutic Use for Patients: Guidance on Safe Dosage, Duration and Clinical Management The tolerable upper intake level set by most guidelines is 100 mg per day. The doses studied for prolactin reduction, 200 to 600 mg per day, are two to six times that upper limit.
The primary risk at those levels is peripheral neuropathy, which is nerve damage in the hands and feet. Symptoms include numbness, tingling, burning sensations, and loss of coordination. In some cases the damage is reversible when B6 is stopped, but in others it persists. The risk increases with both the dose and the duration of use. Reports of neuropathy have surfaced at doses as low as 200 mg per day taken for several months, and the risk climbs significantly above 500 mg per day.
This creates a real dilemma. The doses that showed the most convincing prolactin-lowering effects in clinical studies, 300 to 600 mg per day, are exactly the doses that carry the highest neuropathy risk. You’re essentially in a zone where the supplement might help with one problem while creating another. And unlike a prescription medication where your doctor actively monitors for side effects, many people taking high-dose B6 on their own may not connect the tingling in their fingers to the vitamin they’ve been taking for months.
Why Lower Doses Are Worth Considering Anyway
Much of the online conversation about B6 and prolactin focuses on the high-dose studies, but there’s a practical question that gets less attention: could a more moderate dose do anything useful? The answer depends partly on what you’re trying to achieve.
A systematic review of B6 for premenstrual syndrome found that doses up to 100 mg per day improved both overall PMS symptoms and depressive symptoms compared to placebo.11PubMed Central. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review PMS is not the same as clinical hyperprolactinemia, but prolactin fluctuations do play a role in some premenstrual complaints, and the improvement seen at 100 mg or less is notable because that dose falls at the upper limit of what’s generally considered safe for ongoing use. If your prolactin is only mildly elevated or you’re dealing with cyclical symptoms that may involve prolactin, a dose in the 50 to 100 mg range is a much more reasonable starting point than jumping straight to 600 mg.
That said, no study has specifically tested whether 50 or 100 mg per day lowers prolactin levels in women with confirmed hyperprolactinemia. The evidence at those doses is about symptom relief, not prolactin numbers. If you need your prolactin to come down meaningfully and quickly, a moderate B6 dose probably won’t get you there.
Estrogen, Oral Contraceptives, and B6 Depletion
There’s an additional wrinkle that’s specific to women, and it has to do with how estrogen interacts with B6. Research going back decades has shown that estrogen-containing oral contraceptives can lower blood levels of pyridoxal phosphate, B6’s active form. Estrogen appears to compete with PLP for binding sites on certain enzymes, effectively reducing available B6 activity in the body.12PubMed. The interactions between vitamin B6 and hormones Not every woman on oral contraceptives shows measurably low B6 status, but a subset does.
This matters for the prolactin question because if your functional B6 levels are already compromised by contraceptive use, you might be getting less dopamine support than normal. In theory, that could contribute to mildly elevated prolactin in some women. Whether correcting a B6 shortfall caused by oral contraceptives would normalize borderline-high prolactin hasn’t been directly tested, but it’s a plausible mechanism. For women on estrogen-containing contraceptives who also have mildly elevated prolactin, ensuring adequate B6 intake seems like a reasonable first step before considering megadoses.
The PCOS Connection
Polycystic ovary syndrome introduces yet another layer. A study of women with PCOS found that higher dietary B6 intake was associated with a lower free androgen index, a measure of how much active testosterone is circulating. The relationship was statistically significant and held up even after controlling for other nutritional variables.13PubMed Central. Vitamin B 3 (niacin), B 6 , C, and iron intake are associated with the free androgen index, especially in normoandrogenic polycystic ovary syndrome This wasn’t a supplementation trial, so it doesn’t tell you that taking extra B6 will lower androgens, but it does suggest that B6 status may be tied to the hormonal picture in PCOS in ways that go beyond prolactin.
Women with PCOS often have complex hormonal interactions involving insulin, androgens, and prolactin. Mild hyperprolactinemia is more common in PCOS than in the general population. If B6’s involvement extends to androgen regulation as well as dopamine support, it may play a broader role in the PCOS hormone landscape than the prolactin-specific studies alone would suggest. But again, this is observational data, not proof that supplementation changes outcomes.
What a Realistic Plan Looks Like
If you’re a woman trying to figure out whether B6 could help with elevated prolactin, here’s what the evidence actually supports:
- Get tested first: Know your prolactin number and whether it’s mildly or significantly elevated. The cause of high prolactin matters enormously. Prolactinomas, thyroid disorders, and certain medications all raise prolactin and need their own treatments.
- Mildly elevated prolactin: A dose of 50 to 100 mg per day is within the safer range and may support dopamine production enough to make a modest difference. Monitor your levels after a few months.
- Significantly elevated prolactin with symptoms: The doses shown to meaningfully lower prolactin in studies, 200 to 600 mg per day, come with real neuropathy risk and should only be tried under medical supervision with regular nerve-function monitoring. Prescription dopamine agonists are more effective and better studied for this purpose.
- Postpartum lactation suppression: B6 is not a reliable option. Controlled trials show it works less than half the time, and prescription alternatives are significantly more effective.
The honest picture is that B6 occupies a strange middle ground: there’s enough biological plausibility and a handful of positive findings to keep it interesting, but not enough rigorous evidence to recommend confident dosing. The few studies that exist in women specifically are small, old, or contradicted by larger follow-up work. If you decide to try it, treat it as one variable you’re adjusting while working with a clinician who can track your prolactin and watch for nerve symptoms, not as a standalone fix you manage alone.
Why the Evidence Is So Thin
You might wonder why, after decades of interest, there still isn’t a definitive trial of B6 for prolactin in women. The answer is partly economic: vitamins can’t be patented, so there’s little financial incentive to run the large, expensive trials that would settle the question. The existing pharmaceutical options for hyperprolactinemia, cabergoline in particular, work well enough that the clinical urgency to test an alternative vitamin-based approach is low. Meanwhile, the small positive studies from the 1970s and 1980s were never followed up with larger, better-designed trials. The result is a research gap that leaves patients and practitioners guessing. The in-vitro evidence and the animal data point clearly to a mechanism, but the clinical data in women remain frustratingly sparse. That gap isn’t going to close soon, so anyone making decisions about B6 and prolactin is working with incomplete information whether they like it or not.